Endo announced a consumer level recall of multiple lots of clonazepam ODT tablets because of potential product carton strength mislabeling.
Classification Type: Class 1 Recall
Optum Clinical Services has sent a drug recall notification to potentially impacted members and providers. Below are the notification details.
|
Product
|
Clonazepam Orally Disintegrating Tablets
|
|
Manufacturer
|
Endo
|
|
Recall Identification date
|
11/19/2024
|
|
Affected NDCs
|
49884-306-02, 49884-307-02, 49884-309-02, 49884-310-02
|
|
Look back period
|
7/21/24 - 11/18/24
|
|
Target population for clinical mailing
|
All
|
|
Messaging type
|
Mailing: Members; Direct Message/Fax; Providers
|
|
Data release
|
SS00005114
|
|
Fulfillment due date for NCQA compliance
|
On or before: 12/09/2024
|
|
WHA impacted members
|
4 members
|
|
Date letters were mailed out
|
12/03/2024
|
Last review date: December 4, 2024